China Biologic Products to Present at CCG IR’s China Rising Conference and Oppenheimer’s China Dragon Call Conference in New York
TAIAN CITY, Shandong, China, May 15 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“PRC”), today announced that the Company’s management...
China Biologic Products Receives $5.3 Million Order from Largest Biopharmaceutical Distributor in India
TAIAN CITY, China, April 27 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company received an order fr...
China Biologic Products Completes Acquisition of 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
Acquisition transforms China Biologic into Largest Non-state-owned Producer of Plasma-based Biopharmaceuticals in China TAIAN CITY, China, April 17 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-base...
China Biologic Products Announces Strong 2008 Results
TAI'AN, China, April 2 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), reported financial results for the year ended December...
China Biologic Products Completes Acquisition of 35% Interest in Xi'an Huitian Blood Products Co., Ltd.
TAIAN CITY, Shandong, China, March 24 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), announced that, its indirect majority owned...
China Biologic Products Receives High-Technology Enterprise Certification to Qualify for Preferential Income Tax Rate
TAIAN CITY, China, Feb. 11 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“PRC”), today announced that the Company’s indirect majority-o...
China Biologic Products Enters into Short-Term Loan Agreement
TAI'AN CITY, China, Jan. 14 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that Shandong Taibang Biological Prod...
China Biologic Products Enters Into International Market With its First Sales Order from India
TAIAN CITY, China, Dec. 23 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company made its fi...
China Biologic Products Amends Agreement to Acquire 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
Transaction to create the largest non-state-owned producer of plasma-based products in China TAIAN CITY, China, Dec. 19 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical compani...
China Biologic Products Reports Strong Third Quarter 2008 Results
TAI'AN, China, Nov. 13 /Xinhua-PRNewswire/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today reported financial results for the third quarter end...
China Biologic Products Announces Third Quarter 2008 Results Conference Call
TAI'AN CITY, Shandong, China, Nov. 11 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that it will host a c...
China Biologic Products Provides Preliminary Guidance for 2009 of Revenues of $90 to $100 Million and Net Income of $18 to 22 Million
TAIAN, Shandong, China, Oct. 17 /Xinhua-PRNewswire/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), issues preliminary guidance following the recen...
China Biologic Products Enters Into Agreement to Acquire 35% Interest in Xi'an Huitian Blood Products Co., Ltd. and Introduces Preliminary Guidance for 2009
-- The acquisition will solidify China Biologic's position as the largest non-state-owned supplier of plasma-based pharmaceutical products in China -- Company provides preliminary guidance for 2009 of revenues of $90 to $100 million and net income of $18 to ...
China Biologic Products Enters Into Agreement to Acquire 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
- Transaction to create the largest non-state-owned producers of plasma-based product in China TAIAN CITY, China, Oct. 2 /Xinhua-PRNewswire/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companie...
China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII
TAIAN CITY, Shandong, China, Sept. 17 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“PRC”), today announced that the Comp...
China Biologic Products to Present at the SIG Beijing Management Summit
TAIAN CITY, Shandong, China, Sept. 8 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“PRC”), today announced that the Com...
China Biologic’s Production Facility Renews GMP Certification
TAIAN CITY, Shandong, China, Sept. 4 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (the "PRC"), today announced that on Augu...
China Biologic Products Reports Second Quarter 2008 Results
TAIAN CITY, Shandong, China, Aug. 14 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (“China Biologic,” the “Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“PRC”), today reported financial results...
China Biologic Products Establishes Governance and Nominating Committee and Compensation Committee
TAIAN CITY, Shandong, China, Aug. 14 /Xinhua-PRNewswire/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (“CBP,” or the “Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“PRC”), today announced that, effective August 7, 2008, it...
China Biologic Products Announces Second Quarter 2008 Results Conference Call
TAI’AN CITY, Shandong, China, Aug. 11 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (the “Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“PRC”), today announced that it will host a conference ...
